Schrodinger Inc (SDGR) Stock Analysis

Schrodinger Inc (SDGR) is a publicly traded company in the HEALTHCARE sector. It trades at $14.94, carries a market capitalization of $1.18B. This page summarizes the public market data, fundamentals, and frequently asked questions for SDGR, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - HEALTH INFORMATION SERVICES

Exchange: NASDAQ

Key Metrics

• Price: $14.94
• Market Cap: $1.18B
• EPS: $-1.40
• 52-Week High: $27.63
• 52-Week Low: $10.95

Market Sentiment

Schrodinger Inc currently has a Neutral sentiment score of 0.11.

About Schrodinger Inc

Schrodinger Inc. is a leading provider of a physics-based software platform designed to facilitate the discovery and optimization of novel molecules for drug development and material applications. Headquartered in New York, the company leverages advanced computational techniques to enhance the drug discovery process, ultimately aiming to reduce the time and costs associated with bringing new therapeutics to market. Schrodinger's innovative solutions empower pharmaceutical and biotechnology co...

GNG Research Analysis

GNG Research scores Schrodinger Inc (SDGR) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for SDGR.

Frequently Asked Questions

Does SDGR pay dividends?

Schrodinger Inc (SDGR) does not currently pay a regular dividend.

What is SDGR's market cap?

Schrodinger Inc (SDGR) has a market capitalization of $1.18B with a current stock price of $14.94.